Hpv-2
Vaccine The HPV-2 vaccine is a vaccine that protects people against infection by two types of the human papillomavirus (HPV), types 16 and 18. These two types of HPV are responsible for more than 70% of cervical cancer cases worldwide, and they can also cause genital warts and less common forms of cancer. In addition, HPV-2 can also protect against other HPV types that cause a wide range of cancers including cancer of the vulva, vagina, penis, anus, and head and neck cancers. HPV-2 is an important step in reducing the global burden of HPV-related cancers and other diseases. The vaccine is recommended for both boys and girls, as young as nine years old, to provide protection against HPV infections.
← Journal of Current Viruses and Treatment MethodologiesRelated Articles
1 journal(s) foundCurrent Viruses and Treatment Methodologies
ISSN: 2691-8862
Type: Open Access Journal
Editor: Dr. Anantha Harijith, Associate Professor of Pediatrics, University of Arizona College of Medicine, Tucson, USA
Faculty, Division of Neonatology, University Hospitals Cleveland Medical Center, Cleveland, USA
Journal of Current Viruses and Treatment Methodologies main aim is to provide a comprehensive platform for scientists and academicians all over the world in order to promote and share their findings on the study of virology, viral adaptation and the development and use of antiviral drugs and vaccines to achieve improved outcomes in infection.